Clinical trial
Docetaxel in Treating Patients With Solid Tumors
NCT00003565 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003565 |
|---|---|
| Title | Docetaxel in Treating Patients With Solid Tumors |
| Official title | A Study of Population Pharmacokinetics of Docetaxel (Taxotere) in Caucasian and African-American Cancer Patients |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Breast Cancer, Head and Neck Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | docetaxel |
| Enrollment | 109 |
| Start date | Sep 1, 1998 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 14, 2016 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: